Related Experiment Video

Updated: Jun 27, 2026

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
06:41

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

Hypotonia, weakness, and pontocerebellar hypoplasia in siblings

Chang-Yong Tsao1, Jerry Mendell, Zarife Sahenk

  • 1Department of Pediatrics and Neurology, The Ohio State University, Nationwide Children's Hospital, Columbus, OH 43205, USA. ChangYong.Tsao@nationwidechildrens.org

Seminars in Pediatric Neurology
|December 17, 2008
PubMed

Insights

Familial spinal muscular atrophy with pontocerebellar hypoplasia is a severe genetic disorder. This condition affects infants, leading to significant weakness and developmental issues, often resulting in early mortality.

Area of Science:

  • Pediatric Neurology
  • Genetics
  • Neurodevelopmental Disorders

Background:

  • Spinal muscular atrophy (SMA) is a group of inherited neuromuscular disorders characterized by progressive muscle weakness and atrophy.
  • Pontocerebellar hypoplasia (PCH) is a rare congenital brain malformation involving underdevelopment of the pons and cerebellum.
  • The co-occurrence of SMA and PCH suggests a potential shared genetic or developmental pathway.

Observation:

  • A 6-week-old infant girl presented with severe weakness, hypotonia, gastroesophageal reflux, microcephaly, micrognathia, and high arched palate.
  • Brain imaging revealed pontocerebellar hypoplasia in the affected infant.
  • The patient's younger brother exhibited similar symptoms including generalized hypotonia, weakness, areflexia, tongue fasciculations, and confirmed pontocerebellar hypoplasia via MRI.

Findings:

  • The described cases represent familial spinal muscular atrophy type 1 associated with pontocerebellar hypoplasia.
  • This severe, early-onset condition leads to significant neuromuscular impairment and central nervous system abnormalities.
  • The presentation in siblings highlights a potential genetic etiology for the combined phenotype.

Implications:

  • This review underscores the importance of recognizing the association between SMA and PCH for accurate diagnosis and genetic counseling.
  • Understanding this rare condition can aid in the development of targeted therapeutic strategies for affected children.
  • Further research into the genetic underpinnings of combined SMA and PCH is warranted to elucidate disease mechanisms.

More Related Videos

A Battery of Motor Tests in a Neonatal Mouse Model of Cerebral Palsy10:02

A Battery of Motor Tests in a Neonatal Mouse Model of Cerebral Palsy

Published on: November 3, 2016

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information09:37

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information

Published on: August 15, 2019

Related Concept Videos

Alterations in Muscle Tone ll01:12

Alterations in Muscle Tone ll

Alterations in muscle tone are common manifestations of neurological disorders and reflect dysfunction within different nervous system regions. Spasticity, paratonia, and dystonia represent distinct forms of hypertonia, each with unique mechanisms, clinical features, and diagnostic importance.CharacteristicsSpasticity happens from upper motor neuron lesions and is characterized by velocity-dependent resistance to passive movement. Clinical features include:Exaggerated deep tendon reflexesClonus...
Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...